102 related articles for article (PubMed ID: 27553727)
1. Explorative study on the anticancer activity, selectivity and metabolic stability of related analogs of aminosteroid RM-133.
Perreault M; Maltais R; Dutour R; Poirier D
Steroids; 2016 Nov; 115():105-113. PubMed ID: 27553727
[TBL] [Abstract][Full Text] [Related]
2. Chemical synthesis, NMR analysis and evaluation on a cancer xenograft model (HL-60) of the aminosteroid derivative RM-133.
Maltais R; Hospital A; Delhomme A; Roy J; Poirier D
Steroids; 2014 Apr; 82():68-76. PubMed ID: 24486462
[TBL] [Abstract][Full Text] [Related]
3. Chemical synthesis, cytotoxicity, selectivity and bioavailability of 5α-androstane-3α,17β-diol derivatives.
Ayan D; Maltais R; Hospital A; Poirier D
Bioorg Med Chem; 2014 Nov; 22(21):5847-59. PubMed ID: 25300820
[TBL] [Abstract][Full Text] [Related]
4. Parallel Solid-Phase Synthesis using a New Diethylsilylacetylenic Linker and Leading to Mestranol Derivatives with Potent Antiproliferative Activities on Multiple Cancer Cell Lines.
Dutour R; Maltais R; Perreault M; Roy J; Poirier D
Anticancer Agents Med Chem; 2018; 18(10):1469-1481. PubMed ID: 29521249
[TBL] [Abstract][Full Text] [Related]
5. Minor chemical modifications of the aminosteroid derivative RM-581 lead to major impact on its anticancer activity, metabolic stability and aqueous solubility.
Maltais R; Perreault M; Roy J; Poirier D
Eur J Med Chem; 2020 Feb; 188():111990. PubMed ID: 31893547
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis, NMR characterization, and anticancer activity of androstene derivatives with a C17-side chain.
Djiemeny Ngueta A; Roy J; Poirier D
Steroids; 2022 Oct; 186():109064. PubMed ID: 35714784
[TBL] [Abstract][Full Text] [Related]
7. Design of a Mestranol 2-N-Piperazino-Substituted Derivative Showing Potent and Selective in vitro and in vivo Activities in MCF-7 Breast Cancer Models.
Perreault M; Maltais R; Roy J; Dutour R; Poirier D
ChemMedChem; 2017 Jan; 12(2):177-182. PubMed ID: 28060448
[TBL] [Abstract][Full Text] [Related]
8. Induction of endoplasmic reticulum stress by aminosteroid derivative RM-581 leads to tumor regression in PANC-1 xenograft model.
Perreault M; Maltais R; Roy J; Picard S; Popa I; Bertrand N; Poirier D
Invest New Drugs; 2019 Jun; 37(3):431-440. PubMed ID: 30062573
[TBL] [Abstract][Full Text] [Related]
9. Implication of STARD5 and cholesterol homeostasis disturbance in the endoplasmic reticulum stress-related response induced by pro-apoptotic aminosteroid RM-133.
Perreault M; Maltais R; Kenmogne LC; Létourneau D; LeHoux JG; Gobeil S; Poirier D
Pharmacol Res; 2018 Feb; 128():52-60. PubMed ID: 29287690
[TBL] [Abstract][Full Text] [Related]
10. The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers.
Kenmogne LC; Ayan D; Roy J; Maltais R; Poirier D
PLoS One; 2015; 10(12):e0144890. PubMed ID: 26660672
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase synthesis of libraries of ethynylated aminosteroid derivatives as potential antileukemic agents.
Talbot A; Maltais R; Kenmogne LC; Roy J; Poirier D
Steroids; 2016 Mar; 107():55-64. PubMed ID: 26742630
[TBL] [Abstract][Full Text] [Related]
12. The anti-tumor effects of androstene steroids exhibit a strict structure-activity relationship dependent upon the orientation of the hydroxyl group on carbon-17.
Graf MR; Jia W; Lewbart ML; Loria RM
Chem Biol Drug Des; 2009 Dec; 74(6):625-9. PubMed ID: 19824892
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
Cui HW; Peng S; Gu XZ; Chen H; He Y; Gao W; Lv F; Wang JH; Wang Y; Xie J; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2016 Mar; 111():126-37. PubMed ID: 26866967
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy)benzylidene]androstene derivatives as potent cytotoxic agents.
Bansal R; Guleria S
Steroids; 2008 Dec; 73(14):1391-9. PubMed ID: 18694772
[TBL] [Abstract][Full Text] [Related]
15. Bombesin analogs containing alpha-amino-isobutyric acid with potent anticancer activity.
Prasad S; Mathur A; Gupta N; Jaggi M; Singh AT; Rajendran P; Sanna VK; Datta K; Mukherjee R
J Pept Sci; 2007 Jan; 13(1):54-62. PubMed ID: 17031871
[TBL] [Abstract][Full Text] [Related]
16. Novel 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives as potent anticancer agents - Synthesis, molecular structure, QSAR studies and metabolic stability.
Pogorzelska A; Sławiński J; Żołnowska B; Szafrański K; Kawiak A; Chojnacki J; Ulenberg S; Zielińska J; Bączek T
Eur J Med Chem; 2017 Sep; 138():357-370. PubMed ID: 28688276
[TBL] [Abstract][Full Text] [Related]
17. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
18. Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability.
Sławiński J; Szafrański K; Pogorzelska A; Żołnowska B; Kawiak A; Macur K; Belka M; Bączek T
Eur J Med Chem; 2017 May; 132():236-248. PubMed ID: 28364658
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of (E)-2-benzothiazole hydrazones.
Lindgren EB; de Brito MA; Vasconcelos TR; de Moraes MO; Montenegro RC; Yoneda JD; Leal KZ
Eur J Med Chem; 2014 Oct; 86():12-6. PubMed ID: 25147145
[TBL] [Abstract][Full Text] [Related]
20. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
